The Impact of Late Effects After Treatment for Bladder Cancer on Quality of Life
- Conditions
- Bladder Cancer
- Registration Number
- NCT05195515
- Lead Sponsor
- Aarhus University Hospital
- Brief Summary
Bladder Cancer prognosis, treatment, and subsequent morbidity and mortality vary between the different stages, thus resulting in a different impact on patients' lives. There are some well known late effects of the treatments for bladder cancer, but the knowledge of their impact on patients Quality of Life is sparse. This study aims to determine the prevalence of late effects impact on Quality of Life and potential risk factors for impairment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- All
- Target Recruitment
- 2000
- Patients are eligible if they are referred to a hospital in the Central Region Denmark, due to hematuria between 01/01/2022 and 01/01/2023
- Ability to understand written and oral Danish
- Known Alzheimers disease
- Diagnosed other causes explaining the hematuria
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Health-related Quality of Life 5 years from baseline inclusion Changes in Quality of Life measured using validated instruments
- Secondary Outcome Measures
Name Time Method Prevalence of late effects 5 years from baseline inclusion Based on Patient Reported Outcomes and medical records
Trial Locations
- Locations (5)
Department of Urology, Aarhus University Hospital
🇩🇰Aarhus N, Denmark
Department of Urology, Regional Hospital Gødstrup
🇩🇰Gødstrup, Denmark
Department of Urology, Regional Hospital Horsens
🇩🇰Horsens, Denmark
Department of Urology, Regional Hospital Randers
🇩🇰Randers, Denmark
Department of Urology, Regional Hospital Viborg
🇩🇰Viborg, Denmark
Department of Urology, Aarhus University Hospital🇩🇰Aarhus N, Denmark